DNA replication of first-generation adenovirus vectors in tumor cells

Human Gene Therapy

Volumn 11, Issue 13, 2000, Pages 1933-1948

  Steinwaerder, D S ^a   Carlson, C A ^a   Lieber, A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P16; PROTEIN P53; PROTEIN PRB; TUMOR PROTEIN; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS VECTOR;

ADENOVIRUS; ARTICLE; CANCER THERAPY; CELL CYCLE; CONTROLLED STUDY; DNA REPLICATION; GENE REPRESSION; GENE THERAPY; HUMAN; HUMAN CELL; INTERNALIZATION; NONHUMAN; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE; VIRUS REPLICATION;

ADENOVIRIDAE; ADENOVIRUS E1A PROTEINS; ADENOVIRUS E1B PROTEINS; CELL CYCLE; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA REPLICATION; DNA, VIRAL; GENES, TUMOR SUPPRESSOR; GENETIC VECTORS; HUMANS; RETINOBLASTOMA PROTEIN; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; VIRUS REPLICATION;

EID: 0034284157     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430340050129549     Document Type: Article

References (88)

1. Adenovirus type 5 early region 1b gene product is required for efficient shutoff of host protein synthesis
2. Adhesion receptor expression by hematopoietic cell lines and murine progenitors: Modulation by cytokines and cell cycle status
3. Pre-early adenovirus 5 gene product regulates synthesis of early viral messenger RNAs
4. DNA sequence of deletion/insertion in early region 3 of Ad5 dl 305
5. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells
6. S-phase-specific expression of mammalian ribonucleotide reductase R1 and R2 subunit mRNAs
7. Expression and interactions of human adenovirus oncoproteins
8. Induction of apoptosis and G2/M arrest by infection with replication-deficient adenovirus at high multiplicity of infection
9. In vivo and ex vivo gene therapy strategies to treat tumors using adenovirus gene transfer vectors
10. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B
11. The regulation of E2F by pRB-family proteins
12. The pathway to signal achievement
13. WAF1, a potential mediator of p53 tumor suppression
14. Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: Biological efficacy study
15. Prolonged transgene expression in cotton rat lung with recombinant adenoviruses defective in E2a
16. Cell cycle-dependent expression of mammalian ribonucleotide reductase. Differential regulation of the two subunits
17. Liver regeneration. 2. Role of growth factors and cytokines in hepatic regeneration
18. Cis-acting induction of adenovirus transcription
19. Gradient of RGD-dependent entry of adenoviral vector in nasal and intrapulmonary epithelia: Implication for gene therapy of cystic fibrosis
20. Trans E1 component requirements for maximal replication of E1-defective recombinant adenovirus
21. The early region 1B 55-kilodalton oncoprotein of adenovirus relieves growth restrictions imposed on viral replication by the cell cycle
22. p53 Status does not determine outcome of E1B 55-kilodalton mutant adenovirus lytic infection
23. Roles for the E4 orf6, orf3, and E1B 55-kilodalton proteins in cell cycle-independent adenovirus replication
24. Characteristics of a human cell line transformed by DNA from human adenovirus type 5
25. Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene
26. p53-Dependent cell death/apoptosis is required for a productive adenovirus infection
27. Impaired intracellular trafficking of adeno-associated virus type 2 vectors limits efficient transduction of murine fibroblasts
28. p53-Independent and -dependent requirements for E1B-55K in adenovirus type 5 replication
29. Targeting the replication of adenoviral gene therapy vectors to lung cancer cells: The importance of the adenoviral E1b-55kD gene
30. ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents
31. Intravenous administration of ONYX-015, a selectively replicating adenovirus, induces antitumoral efficacy
32. E1A-dependent trans-activation of the human MYC promoter is mediated by the E2F factor
33. Adenovirus E1A under the control of heterologous promoters: Wide variation in E1A expression levels has little effect on virus replication
34. Human adenoviral vectors for gene transfer into mammalian cells
35. Effect of adenovirus on host cell DNA synthesis in synchronized cells
36. Adenoviruses
37. Common control of the heat shock gene and early adenovirus genes: Evidence for a cellular E1A-like activity
38. Vector development: A major obstacle in human gene therapy
39. An adenovirus type 5 early gene function regulates expression of other early viral genes
40. A cell cycle regulator potentially involved in genesis of many tumor types
41. Replicating viruses as selective cancer therapeutics
42. An adenovirus E1A-like transcription factor is regulated during the differentiation of murine embryonal carcinoma stem cells
43. Recombinant adenoviruses with large deletions generated by Cre-mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in vivo
44. Nuclear import of Moloney murine leukemia virus DNA mediated by adenovirus preterminal protein is not sufficient for efficient retroviral transduction in nondividing cells
45. p53 Status and the efficacy of cancer therapy in vivo
46. The hsp70 gene CCAAT-binding factor mediates transcriptional activation by the adenovirus E1a protein
47. The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7a, and 12
48. Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy
49. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
50. Phenotypical stability of a human hepatoma cell line, HuH-7, in long-term culture with chemically defined medium
51. Persistence of recombinant adenovirus in vivo is not dependent on vector DNA replication
52. Role of alpha(v) integrins in adenovirus cell entry and gene delivery
53. Mechanism of activation of early viral transcription by the adenovirus E1A gene product
54. Mutations and altered expression of p16INK4 in human cancer
55. Localization of the adenovirus early region 1B 55-kilodalton protein during lyric infection: Association with nuclear viral inclusions requires the early region 4 34-kilodalton protein
56. The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins
57. Integration of murine leukemia virus DNA depends on mitosis
58. Replication of ONYX-015, a potential anticancer adenovirus, is independent of p53 status in tumor cells
59. Adenovirally transferred p16INK4/CDKN2 and p53 genes cooperate to induce apoptotic tumor cell death
60. Different human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes
61. Adenoviridea
62. Interaction of human adenovirus serotype 2 with human lymphoid cells
63. How proteins enter the nucleus
64. Control of cell division by aphidicolin without adverse effects upon resting cells
65. Interleukin 6 enhances a cellular activity that functionally substitutes for E1A protein in transactivation
66. The role of p53 in coordinated regulation of cyclin D1 and p21 gene expression by the adenovirus E1A and E1B oncogenes
67. Infectivity and expression of the early adenovirus proteins are important regulators of wild-type and DeltaE1B adenovirus replication in human cells
68. Insulation from viral transcriptional regulatory elements improves inducible transgene expression from adenovirus vectors in vitro and in vivo
69. Microtubule-dependent plus- and minus end-directed motilities are competing processes for nuclear targeting of adenovirus
70. Differential expression and cell cycle regulation of the cyclin-dependent kinase 4 inhibitor p16Ink4
71. Transactivation of the human cdc2 promoter by adenovirus E1A in cycling cells is mediated by induction of a 110-kDa CCAAT-box-binding factor
72. Adenovirus E1A proteins induce apoptosis by both p53-dependent and p53-independent mechanisms
73. Terminally differentiated skeletal myotubes are not confined to G0 but can enter G1 upon growth factor stimulation
74. Expressions of cell cycle regulators in human colorectal cancer cell lines
75. The replicative capacities of large E1B-null group A and group C adenoviruses are independent of host cell p53 status
76. The replication in vitro of the gammaherpesvirus bovine herpesvirus 4 is restricted by its DNA synthesis dependence on the S phase of the cell cycle
77. Adenovirus DNA replication
78. Cancer gene therapy: Hard lessons and new courses
79. p53 Selective and nonselective replication of an E1B-deleted adenovirus in hepatocellular carcinoma
80. Regulation of the cell cycle by viral oncoproteins
81. The retinoblastoma protein and cell cycle control
82. Recombinant, replication-defective adenovirus gene transfer vectors induce cell cycle dysregulation and inappropriate expression of cyclin proteins
83. Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types
84. Adenoviral vectors capable of replication improve the efficacy of HSVtk/GCV suicide gene therapy of cancer
85. p21 Is a universal inhibitor of cyclin kinases
86. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy
87. Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs
88. Detection of wild-type contamination in a recombinant adenoviral preparation by PCR